Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer

Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer

Prolactin receptor (PRLR) and epidermal growth factor receptor (EGFR/ERBB) signaling pathways activated by prolactin (PRL) and epidermal growth factor (EGF), have a major role in the mammary gland development and in the etiology of breast cancer, respectively. ER+ breast tumors comprise up to 75% of...

Full description

Bibliographic Details
Main Authors: Raghuveer Kavarthapu, Rajakumar Anbazhagan, Maria L. Dufau
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
breast cancer
PRLR
EGFR
HER2
signaling pathways
Online Access:https://www.mdpi.com/2072-6694/13/18/4685

Internet

https://www.mdpi.com/2072-6694/13/18/4685

Similar Items